LMDXF — LumiraDx Share Price
0.000.00%
Last trade - 00:00- $1.98m
- $379.27m
- $254.48m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.02 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -121.19% | ||
| Return on Equity | n/a | ||
| Operating Margin | -241.22% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 25.39 | 23.14 | 139.15 | 421.43 | 254.48 | 89.92 | 148.31 | 77.94% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
LumiraDx Limited is a point of care diagnostic company. The Company is focused on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need. The Company has developed and launched the LumiraDx Platform, which is an integrated system comprised of a small, versatile Instrument, low-cost microfluidic Test Strips, and seamless, secure digital connectivity. The Company offers a menu of lab comparable tests on a single portable platform, with more than 30 assays on the market and in various stages of development, covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders. It also supports laboratory testing in an accessible high-throughput format to leverage molecular laboratory operations. Its diagnostic testing solutions are being deployed globally by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools and others.
Directors
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- August 24th, 2016
- Public Since
- March 9th, 2021
- No. of Employees
- 1,210
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 164,321,766
- Address
- Windward 3, Regatta Office Park, GRAND CAYMAN, KY1-1108
- Web
- https://www.lumiradx.com/
- Phone
- +44 1786430411
- Auditors
- KPMG LLP
Upcoming Events for LMDXF
Similar to LMDXF
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
Acutus Medical
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
FAQ
What is the LumiraDx share price?
As of Today at 21:53 UTC, shares in LumiraDx are trading at $0.01. This share price information is delayed by 15 minutes.
How has the LumiraDx share price performed this year?
Shares in LumiraDx last closed at $0.01 and the price had moved by -97.05% over the past 365 days. In terms of relative price strength the LumiraDx share price has underperformed the S&P500 Index by -97.53% over the past year.
What are the analyst and broker recommendations for LumiraDx?
The overall consensus recommendation for LumiraDx is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the LumiraDx dividend yield?
LumiraDx does not currently pay a dividend.
Does LumiraDx pay a dividend?
LumiraDx does not currently pay a dividend.
When does LumiraDx next pay dividends?
LumiraDx does not currently pay a dividend.
How do I buy LumiraDx shares?
To buy shares in LumiraDx you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of LumiraDx?
As of the previous close price of $0.01, shares in LumiraDx had a market capitalisation of $2.20m.
Where are LumiraDx shares listed?
Here are the trading details for LumiraDx:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: LMDXF
What kind of share is LumiraDx?
Based on an overall assessment of its quality, value and momentum LumiraDx is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a LumiraDx share price forecast for 2024?
The analyst consensus target price for shares in LumiraDx is $0.65. That is 4750.75% above the last closing price of $0.01.
Analysts covering LumiraDx currently have a consensus Earnings Per Share (EPS) forecast of -$0.39 for the next financial year.
What is the trend in the LumiraDx share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like LumiraDx. Over the past six months, its share price has underperformed the S&P500 Index by -83%.
As of the last closing price of $0.01, shares in LumiraDx were trading -81.65% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the LumiraDx PE Ratio?
The LumiraDx PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of LumiraDx?
We do not have data on LumiraDx's directors